Insights Into Nosocomial Infection and Environmental Contamination
March 31st 2009Microbes collect on fabric, objects, and surfaces in the hospital environment, but what role do they play in disease transmission, and how can a more sterile environment be maintained? The current findings sometimes leave us with more questions than answers. Food for thought was presented at a poster session that focused on nosocomial infections and environmental contamination at the joint 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Diseases Society of America 46th Annual Meeting, which convened October 25-28, 2008, in Washington, DC.
Delusional Parasitosis and Factitious Dermatitis
March 31st 2009Delusional parasitosis and factitious disorder are psychiatric illnesses that are often encountered by clinicians. The differential diagnosis can be tricky, but treatment, which may include referral to a mental health specialist, may be trickier.
Adult and Adolescent Immunizations: When to Recommend the New Vaccines
March 31st 2009Vaccination rates in adults are lower than those in children, but the consequences of lack of immunization in adults are just as significant. Barriers to adult immunization include patients’ lack of knowledge or misconceptions about vaccines and health care providers’ failure to recommend vaccination.1
Screening Deficits, Inadequate Guidance, and the Growing Chlamydia Infection Epidemic
March 31st 2009The CDC recommends that sexually active adolescent girls be screened for Chlamydia trachomatis infection at least annually and that all sexually active women aged 20 to 25 years and women aged 25 years or older who have risk factors also receive an annual screening.1 How well are these screening practices being observed and what are the implications?
Managing CA-MRSA Infections: Current and Emerging Options
March 30th 2009Methicillin-resistant Staphylococcus aureus (MRSA) must be recognized now as one of the most common causes of infections acquired in the community. The majority of these infections involve the skin and soft tissue structures and confer significant morbidity on those affected.
Immunosuppression and Infection Risk in SOT Recipients
March 30th 2009With the introduction of immunosuppressive drugs, solid organ transplant (SOT) has progressed such that potential recipients significantly outnumber available organs. In 2007, there were 14,394 donors of 28,353 organs, but 98,645 persons were on a waiting list as of March 2008.1
Catastrophic Antiphospholipid Syndrome in Secondary Syphilis
March 27th 2009Catastrophic antiphospholipid syndrome (CAPS), first described by Asherson and colleagues1 in 1992, refers to a clinical scenario in which multiple vascular occlusive events involving small vessels that supply blood to organs occur over a short period.
Sexually Transmitted Viral Infections in Women: HIV, HSV, and HPV
March 26th 2009Over the past 15 years in the United States, HIV/AIDS has become increasingly common among women. In 1990, women made up only 11% of the newly reported cases of AIDS.1 In 2006, 27% of newly reported AIDS cases were in women.2
Science and Policy: A Perpetual Dilemma
March 14th 2009Many policy watchers are anticipating a golden age of science-led policy in health and environment under the presidential leadership of Barack Obama. After 8 years of frustration at bowdlerized reports, derailed rule making, and policies based on stubbornly held beliefs-despite the facts pointing government policies in another direction-it’s time for clearheaded thinking and the best use of sound information to formulate health and environment policy-even when a policy needs to be based on findings that make us uncomfortable. Of course, it’s this last condition that’s the kicker: none of us want to feel anything other than good when a policy is enacted, and that’s not always going to be the case.
Preaching to the Choir: Advocating Routine HIV Testing
March 14th 2009For the first 25 years of the AIDS epidemic, HIV testing was treated differently from all other types of medical diagnostic testing. Formal pretest and posttest counseling was required, and patients had to give written informed consent before being tested. The need for testing was focused primarily on assessment of risk, which required the taking of a detailed sexual and drug use history for which few clinicians had the time, training, or inclination. The rationale for this particular form of “HIV exceptionalism” was mostly historical, dating back to times when concerns about stigma; discrimination; and loss of insurance, jobs, or housing outweighed any modest benefit that might have been derived from early medical care.
Digestive Diseases Cost $141.8 Billion Annually
March 14th 2009Digestive diseases are costly to manage, with annual costs totaling $141.8 billion in 2004 (Figure 1), according to an NIH report. Direct costs associated with digestive diseases jumped from $85 billion in 1998 to nearly $98 billion in 2004. Prescription drug costs alone were $12.3 billion. Indirect costs for digestive diseases more than doubled, from $20 billion in 1998 to $44 billion in 2004, of which $32.8 billion was associated with lost productivity caused by increased mortality.
Genetic Polymorphism and Major Depression: New Theories
March 14th 2009Genetic studies are slowly leading to a better understanding of certain diseases as well as progress toward individualized drug therapy. Developments in DNA sequencing make it relatively simple to look for allelic (ie, alternative) versions of a gene by examining samples of a specific gene taken from different members of a population (or from a heterozygous individual). Genetic variants that appear in at least 1% of a population are called polymorphisms. With the cutoff at 1%, one does not get sidetracked by spontaneous mutations that may have occurred in-and spread by the descendants of-a single family.
Insulin: A Possible Treatment for AD?
March 14th 2009Researchers at Northwestern University, Evanston, Ill, report that insulin, by shielding memory-forming synapses from injury, may slow or prevent the damage and memory loss caused by amyloid b–derived diffusible ligands (ADDLs)-toxic neuroproteins associated with Alzheimer disease (AD). Findings of the study, which provides additional evidence that AD may be caused by a new, third form of diabetes, were published in the February 10 issue of the Proceedings of the National Academy of Sciences of the United States of America.